[nootropics_archive2 graphic]
  Nootropics Archive / Nootropic Plants / Herbs / Ginkgo Biloba


Ginkgo Biloba

From: spedge@csd4.csd.uwm.edu (Mary Mirtens) Newsgroups: alt.drugs Subject: Re: Gingko Biloba Date: 29 Oct 1993 01:54:58 GMT Message-ID: <2apt5iINNfac@uwm.edu>

From article , by james@cadillac.Eng.Sun.COM Jack Mahenglin, Esq.: > I've been taking Gingko as a vitamin supplement and have noticed a marked > increase in the level of intensity I am able to think. It's supposed to > be a "smart" drug, but I didn't realize the effects were so apparent. Supposedly,

From Smart Drugs and Nutrients:

GINKGO BILOBA: A Nootropic Herb?

Ginkgo biloba is the oldest species of tree known. Extracts from the leaves of the ginkgo biloba tree have been used by Chinese medicine for thousands of years. European physicians write over 1.2 million prescriptions per month for it. Ginkgo biloba is used to improve cerebral circulation, mental alertness, and overall brain functioning.

More than 34 human studies on ginkgo have been published since 1975, show ing that ginkgo works by increasing blood flow throughout the body and brain. Ginkgo increases the productions of adenosine triphosphate (ATP, the universal energy molecule). It also improves the brain's ability to metabolize glucose, prevents platelet aggregation inside arterial walls by keeping them flexible, improves the transmission of nerve signals, and acts as a powerful antioxidant.

Ginkgo biloba leaf is effective for people with symptoms of reduced blood flow to the brain and extremities. It has been shown to be helpful with many of the complaints of the elderly such as: memory loss, slow thinking and reasoning, depression, dizziness, ringing in the ears, headaches, and senile macular degeneration (a major cause of blindness).

One study even shows significant improvement in people who have both Parkinson's and Alzheimer's disease. In this study 25 people w/ Parkinson's disease and signs of Alzheimer's disease were given ginkgo extract daily for one year. They were tested with standard tests, clinical evaluations, and a new computerized EEG. The scores improved significantly.

CITE: Funfgeld, E.W. "A natural and broad spectrum nootropic substance treatment of SDAT - the gingko biloba extract". from Progress in Clinical and Biological Research, 1989, 317 (pp 1247-1260)

One study does not prove that Gingko biloba is efficacious in the treatment of these diseases. However, ginkgo is safe, inexpensive and easily obtain ed, and people with Parkingsons and/or Alzheimer's might consider experimenting with it.

PRECAUTIONS: No negative effects have been reported in the literature even in very large quantities.

DOSAGE: Most research has been done with a gingko biloba extract which contained a 24% concentration of flavinoid extract. At this strength, the usual dosage is 120-160mg per day taken in three divided doses. However, many gingko products are lower in potency, and may require dosages as high as 1000mg per day. Three to six months is probably needed to evaluate the results.

Buy the books!

"Smart Drugs and Nutrients" by Ward Dean & John Morgenthaler (1990) ISBN# 0-9627418-9-2 ($12.95)

"Smart Drugs II" by Ward Dean / John Morgenthaler / Steven Wm. Fowkes (1993) ISBN# 0-9627418-7-6 ($14.95)

SD2 covers totally different material than the first book: Deprenyl, Melatonin, Milacemide, Nimodipine, Phosphatidylserine, Pregnenolone, Ondansetron and Zatosetron.

The first book has: Pyrrolidone types (Piracetam, Oxiracetam), Hydergine, Vasopressin, Fipexide, Vinopocetine, Acetyl-L-Carnitine, Centrophenoxine, Choline, AL721, DHEA, DMAE, Gerovital GH-3, Ginkgo, Ginseng, Idebenone (CoQ10), Phenytoin (dilantin), Inderal, Vincamine, etc.

 

Previous   Next

This page was created at 11/6/98; 7:00:40 PM and was last built on 4/29/99; 3:33:27 PM.

Thank you for visiting. chris@hyperreal.org

Hyperreal